# Efficacy of Aprepitant (Emend®) in Children

> **NCT01661335** · PHASE3 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 19 (actual)

## Conditions studied

- Nausea
- Vomiting
- Childhood Cancer

## Interventions

- **DRUG:** Ondansetron, dexamethasone, aprepitant
- **DRUG:** Ondansetron, Dexamethasone, placebo

## Key facts

- **NCT ID:** NCT01661335
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-01
- **Primary completion:** 2017-06-29
- **Final completion:** 2017-06-29
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661335, "Efficacy of Aprepitant (Emend®) in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01661335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*